BeStock  
Stocks › Biotechnology › TRVI

Trevi Therapeutics TRVI

US equityMarket cap rank #2802Biotechnology
$13.72 −$0.19 (-1.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $13.72 0.00%
Open$13.97
Prev close$13.91
Day range$13.51 – $14.11
Volume1.72M
Market cap$1.95B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$29.00+111.4% vs. price
  • Buy 100%
Low $23.00Now $13.72Avg $29.00High $40.00

Recent rating changes

The last 20 actions on file set price targets from $20.00 to $40.00, averaging $26.30.

DateFirmRatingTarget
21 Sep 2026 H.C. Wainwright BUY $24.00
13 Aug 2026 JonesTrading BUY $28.00
11 Aug 2026 H.C. Wainwright BUY $24.00
10 Aug 2026 Morgan Stanley BUY $23.00
7 Aug 2026 Raymond James BUY $40.00
7 Aug 2026 Morgan Stanley BUY $23.00
7 Aug 2026 Stifel BUY $30.00
7 Aug 2026 Needham BUY $23.00
7 Aug 2026 B. Riley Securities BUY $31.00
7 Aug 2026 Oppenheimer BUY $25.00
6 Aug 2026 Cantor Fitzgerald BUY $30.00
21 Jul 2026 BMO Capital BUY $36.00
20 Jul 2026 H.C. Wainwright BUY $24.00
17 Jul 2026 Morgan Stanley BUY $20.00
17 Jul 2026 Needham BUY $23.00
20 May 2026 Needham BUY $23.00
8 May 2026 Stifel BUY $30.00
8 May 2026 H.C. Wainwright BUY $21.00
8 May 2026 Oppenheimer BUY $24.00
6 May 2026 JonesTrading BUY $24.00

Discussion

No comments yet — be the first to weigh in on TRVI.

Leave a comment

Scroll to Top